Selected Issues Papers

Productivity Shocks to the Pharmaceutical Sector and the Danish Economy: Denmark

By Kotaro Ishi

December 24, 2024

Download PDF More Formats on IMF eLibrary Order a Print Copy
More formats on IMF eLibrary Order a Print Copy

Preview Citation

Format: Chicago

Kotaro Ishi. "Productivity Shocks to the Pharmaceutical Sector and the Danish Economy: Denmark", Selected Issues Papers 2024, 043 (2024), accessed December 25, 2024, https://doi.org/10.5089/9798400296383.018

Export Citation

  • ProCite
  • RefWorks
  • Reference Manager
  • BibTex
  • Zotero
  • EndNote

Summary

The pharmaceutical industry in Denmark has grown rapidly in recent years. This paper discusses the macroeconomic impact of the pharmaceutical sector. The analysis focuses on Novo Nordisk, the leading pharmaceutical company in Denmark, and its productivity impact on the rest of the economy. Empirical evidence suggests only weak correlations between productivity shocks at Novo Nordisk and overall economic growth, as well as between Novo Nordisk’s productivity and that of other firms. However, we find evidence of a significant within-industry spillover effect in the pharmaceutical sector.

Subject: Employment, Exports, International trade, Labor, Labor productivity, Production, Productivity

Keywords: Balance of payments statistics, Employment, Exports, Labor productivity, Output gap, Pharmaceutical, Productivity, Productivity, Spillovers

Publication Details

You May Also Be Interested In...

Trade Policy and Jobs in Vietnam: The Unintended Consequences of US-China Trade Tensions

December 23, 2024

Republic of Kosovo: Selected Issues

December 23, 2024

Australia: 2024 Article IV Consultation-Press Release; and Staff Report

December 23, 2024

Chasing the Dream: Industry-Level Productivity Developments in Europe

December 20, 2024